Publications
224
Citations
11,834
Est. group size
~11
Recurring co-author estimate
Active years
41
Publishing since 1986
Typically publishes in teams of ~9 · 10% small-team papers (≤3 authors) · across 12 venues
- Terminal Resilience: Patient Factors Contributing to a Prolonged Active Dying Phase
Journal of Pain and Symptom Management · 2026
- Time is of the Essence: Evaluating Short-Term Prognosis Tools at End-of-Life in Non-Cancer Patients
Journal of Pain and Symptom Management · 2026
- Identifying Nonresponders to SGLT2 Inhibitors in the CREDENCE Trial: Biomarker-Guided Approach for Targeting Alternative Therapies
Journal of the American Society of Nephrology · 2025
- Parsimonious Cardiorenal Prognostic Algorithm: Web-Based Risk Calculator for Predicting Cardiovascular and Kidney Outcomes in Type 2 Diabetes and CKD
Journal of the American Society of Nephrology · 2025
- Baseline and One-Year Percent Changes in Concentration of Plasma Proteins as Predictors of ESKD in the Chronic Renal Insufficiency Cohort (CRIC) with Type 2 Diabetes
Journal of the American Society of Nephrology · 2025
- Joslin Kidney Panel of Circulating Proteins
Clinical Journal of the American Society of Nephrology · 2025
- Urinary Complement proteome strongly linked to diabetic kidney disease progression
Nature Communications · 2025
- Modifying Effect of Albuminuria on the Association between Joslin Kidney Panel Biomarkers and Kidney Failure among Patients with Diabetes: Findings from the ACCORD/ACCORDION Trial
Journal of the American Society of Nephrology · 2024
- Associations of Biomarkers of Tubular Injury and Inflammation with Biopsy Features in Type 1 Diabetes
Clinical Journal of the American Society of Nephrology · 2023
- A Prospective Study of Urinary Complement Proteins in Early Diabetic Kidney Disease in Type 1 Diabetes
Journal of the American Society of Nephrology · 2022
- 405-P: Glycemic Control Impacts Renal Function Decline among People with Type 1 Diabetes after the Onset of Diabetic Kidney Disease
Diabetes · 2022
- Neuroblastoma suppressor of tumorigenicity 1 is a circulating protein associated with progression to end-stage kidney disease in diabetes
Science Translational Medicine · 2022
- Results of untargeted analysis using the SOMAscan proteomics platform indicates novel associations of circulating proteins with risk of progression to kidney failure in diabetes
Kidney International · 2022
- Contemporary Conditions of Information Security
Sciendo eBooks · 2021
- Association of Coding Variants in Hydroxysteroid 17-beta Dehydrogenase 14 (HSD17B14) with Reduced Progression to End Stage Kidney Disease in Type 1 Diabetes
Journal of the American Society of Nephrology · 2021
- Stroke×10
- Journal of the American Society of Nephrology×7
- JAMA Network Open×4
- Journal of Alzheimer s Disease×4
- Kidney International×3
- John Neuhaus
Medicine · University of Michigan
- Sujuan Gao
Medicine · Indiana University
- Rachael T. Whitney
Medicine · University of Michigan
- Deborah A. Levine
Medicine · University of Michigan
- Wan-Ling Hsu
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile